23andMe raises $79.1M toward $150M target

Genomics company 23andMe Inc. (Mountain View, Calif.) has raised $79.1 million of a planned $150 million round of funding, according to an SEC filing. The company declined to comment.

In March, 23andMe said it would launch a therapeutics group to identify novel drug targets mined from the company's database of customer DNA sequences (see BioCentury Extra, March 12). ...